Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
HTML
PDF
Details
Locations
Year:
2020
Type:
review
Source:
Acta Diabetologica
DOI:
10.1007/s00592-020-01539-z
Authors:
Sebastiano Bruno Solerte,
Antonio Di Sabatino,
Massimo Galli,
Paolo Fiorina
Institutions:
University of Pavia,
Policlinico San Matteo Fondazione,
University of Milan,
Luigi Sacco Hospital,
ASST Fatebenefratelli Sacco,
Boston Children's Hospital,
Harvard University
show all 7
Language:
English
Topic:
COVID-19 Clinical Research Studies
Subfield:
Infectious Diseases
Field:
Medicine
Domain:
Health Sciences
Keywords:
COVID-19 pandemic,
SARS-CoV-2,
DPP-4 inhibition,
CD26,
ACE2,
viral entry,
cytokine storm,
DPP-4 inhibitors,
type 2 diabetes,
antiviral therapy,
lung inflammation
show all 11
SDG:
Good health and well-being
Open Access status:
bronze
Funder:
Ministero della Salute
Award:
G6130281517
OpenAlex ID:
W3034081489
FWCI:
2.004
Cites:
47
Cited by:
207
Related to:
10